Endothelial dysfunction induced by type 2 diabetes mellitus and fibrinolytic activity

American Journal of Biochemistry and Biotechnology

Volumn 6, Issue 2, 2010, Pages 103-110

  Sakr, Hussein F ^a  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Endothelial dysfunction; Endothelin 1; Fibrinolysis; Type 2 diabetes mellitus

Indexed keywords

DEGRADATION;

ENDOTHELIAL DYSFUNCTION; ENDOTHELIN-1; FIBRINOLYSIS; FIBRINOLYTIC ACTIVITY; PLASMINOGEN ACTIVATOR INHIBITOR-1; PROTEOLYTIC MECHANISMS; TISSUE PLASMINOGEN ACTIVATOR; TYPE 2 DIABETES MELLITUS;

RATS;

ENDOTHELIN 1; FIBRIN; FIBRIN DEGRADATION PRODUCT; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMER; STREPTOZOCIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; EUGLOBULIN LYSIS TEST; FIBRINOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; THROMBOSIS;

RATTUS;

EID: 77954653441     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbbsp.2010.103.110     Document Type: Article

References (48)

1. Bastard, J.P., H. Vidal, C. Jarde, E. Bruckert and D. Robin et al., 2000. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects. Int. J. Obes. Relat. Metab. Disord., 24: 70-74. PMID: 10702753
2. Calles-Escandon, J. and M. Cipolla, 2001. Diabetes and endothelial dysfunction: A clinical perspective. Endocr. Rev., 22: 36-52. PMID: 11159815
3. Cusi, K., K. Maezono, A. Osman, M. Pendergrass and M.E. Patti et al., 2000. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest., 105: 311-320. PMID: 1067535
4. Esposito, K., G. Nicoletti and D. Giugiliano, 2002. Obesity, cytokines and endothelial dysfunction: A link for the raised cardiovascular risk associated with visceral obesity J. Endocrinol. Invest., 25: 646-649. PMID: 12150343
5. Federici, M., R. Menghini, A. Mauriello, M.L. Hribal and F. Ferrelli et al., 2002. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation, 106: 466-472. PMID: 12135947
6. Ferri, C., C. Bellini, G. Desideri, G. De Mattia and A. Santucci, 1996. Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care, 19: 504-506. PMID: 8732718
7. Garg, A. and S.M. Grundy, 1990 Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. J. Am. Med. Assoc., 264: 723-726. PMID: 2374275
8. Garvey, W.T., S. Kwon, D. Zheng, S. Shaughnessy and P. Wallace et al., 2003. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes, 52: 453-462. PMID: 12540621
9. Giugliano, D., R. Marfella, L. Coppola, G. Verrazzo and R. Acampora et al., 1997. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation, 95: 1783-1790. PMID: 9107164
10. Hajjar, K.A., 2003. The Molecular Basis of Fibrinolysis. In: Hematology of Infancy and Childhood. Nathan, D.G. S.H. Orkin, D. Ginsburg and A.T. Look (Eds.). WB Saunders, Philadelphia, pp: 1497.
11. Hamsten, A., B. Wiman, F.U. De and M. Blomback, 1985. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med., 313: 1557-1563. PMID: 3934538
12. Hickey, K.A., G.M. Rubanyi, R.J. Paul and R.F. Highsmith, 1985. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am. J. Physiol., 248: 550-556. PMID: 3993773
13. Ishibashi, K.I., T. Imamura, P.M. Sharma, J. Huang and S. Ugi et al., 2001. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. J. Clin. Invest., 107: 1193-1202. DOI: 10.1172/JCI11753
14. Jackson M. B., Y. Osei Suzette, Ahima and S. Rexford, 2005. The endocrine role of adipose tissue: Focus on adiponectin and resistin. Current opinion in endocrinology and diabetes. The endocrine role of adipose tissue: Focus on adiponectin and resistin. Endovrinol. Diabetes, 12: 163-170.
15. Jian, L., Q. Josephine, T. Joyce, K.H. Christina and S. Cynthia et al., 1998. Nongenetic mouse models of non-insulin dependent diabetes mellitus. Metabolism, 47: 663-668.
16. Kaji, T., C. Yamamoto, M. Sakamoto and R. Koizumi, 1992. Endothelin modulation of tissue plasminogen activator release from human vascular endothelial cells in culture. Blood Coagul Fibrinol., 3: 5-10. PMID: 1377954
17. Kakizawa, H., M. Itoh, Y. Itoh, S. Mamura and Y. Ishiwata et al., 2004. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism, 53: 550-555. PMID: 15131756
18. Kedzierski, R.M. and M. Yanagisawa, 2001. Endothelin system: The double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol., 41: 851-876. PMID: 11264479
19. Koopman, J., F. Haverkate, P. Koppert, W. Nieuwenhuizen and E.J.P. Brommer et al., 1987. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J. Lab. Clin. Med., 109: 75. PMID: 3540164
20. Koppert, P.W., E. Hoegee-de Nobel and W. Nieuwenhuizen, 1988. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Thromb. Haemost., 59: 310. PMID: 3133813
21. Koppert, P.W., W. Kuipers, B. Hoegee-de Nobel, E.J.P. Brommer and J. Koopman et al., 1987. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma. Thromb. Haemost., 57: 25. PMID: 7937785
22. Levin, E.G., K.G. Osborn and W.D. Schleuning, 1998. Vessel-specific gene expression in the lung: Tissue plasminogen activator is limited to bronchial arteries and pulmonary vessels of discrete size. Chest, 114: 68. PMID: 9676639
23. Lidbury, P.S., R. Korbut and J.R. Vane, 1990. Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Br. J. Pharmacol., 101: 527-530. PMID: 2127549
24. Lopez-Garcia, E., M.B. Schulze, J.B. Meigs, J.E. Manson and N. Rifai et al., 2005. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutrit., 135: 562-566. PMID: 15735094
25. Loskutoff, D.J. and F. Samad, 1998. The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler. Thromb. Vasc. Biol., 18: 1-6. PMID: 9445248
26. Makita, Z., S. Radoff, E.J. Rayfield, Z. Yang and E. Skolnik et al., 1991. Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med., 325: 836-842. http://www.jci.org/articles/view/116696/files/pdf
27. Masaoka, H., R. Suzuki, Y. Hirata, T. Emori and K. Hirakawa, 1989. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet, 2: 1402. PMID: 8301307
28. Migdalis, I.N., K. Kalogeropoulou, K.D. Karmaniolas, N. Varvarigos and P. Cordopatis, 2000. Plasma level of endothelin and early carotid atherosclerosis in diabetic patients. Res. Commun. Mol. Pathol. Pharmacol., 108: 15-25. PMID: 11758970
29. Mohanty, P., W. Hamouda, R. Garg, A. Aljada, A. Ghanim and P. Dandona, 2000. Glucose challenge stimulates Reactive Oxygen Species (ROS) generation by leucocytes. J. Clin. Endocrinol. Metab., 85: 2970-2973. PMID: 10946914
30. Mohanty, P., H. Ghanim, W. Hamouda, A. Aljada, R. Garg and P. Dandona, 2002. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am. J. Clin. Nutr., 75: 767-772. PMID: 11916766
31. Montagnani, M., L.C. Ravichandran, H. Chen, D.L. Esposito and M.J. Quon, 2002. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol. Endocrinol., 16: 1931-1942. http://mend.endojournals.org/cgi/content/full/16/8/1931
32. National Institute of Health, 1996. Guide for the care and use of laboratory animals. DHEW Publication (NIH), Office of Science and Health Reports, DRR/NIH, Bethesda, MD.
33. Oishi, K., N. Ohkura, M. Wakabayashi, H. Shirai and K. Sato et al., 2006. Clock is involved in obesity- induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression. Thromb. Haemost., 4: 1774-1780. DOI: 10.1097/MOL.0b013e32814e6d29
34. Osman, A.A., M. Pendergrass, J. Koval, K. Maezono and K. Cusi et al., 2000. Regulation of MAP kinase pathway activity in vivo in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 278: 992-999. hppt://ajpendo.physiology.org/cgi/reprint/278/6/E992.pdf
35. Owensby, D.A., P.A. Morton and A.L. Schwartz, 1989. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2. J. Biol. Chem., 264: 18180-18187. http://www.jbc.org/content/264/30/18180.full.pdf
36. Pandolfi, A., A. Giaccari, C. Cilli, M.M. Alberta and L. Morviducci et al., 2001. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetologica, 38.71-76.
37. Quehenberger, P., M. Exner, R. Sunder-Plassmann, K. Ruzicka and C. Bieglmayer et al., 2002. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res., 90: 711-718. PMID: 11934840
38. Samad, F., K.T. Uysal, S.M. Wiesbrock, M. Pandey and G.S. Hotamisligil et al., 1999. Tumor necrosis factor alpha is a key component in the obesity- linked elevation of plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA., 96: 6902-6907. http://endo.endojournals.org/cgi/content/abstract/139/12/4832
39. Shoelson, S.E., J. Lee and A.B. Goldfine, 2006. Inflammation and insulin resistance. J. Clin. Invest., 116: 1793-1801. DOI: 10.1172/JCI29069E1
40. Tabengwa, E.M., R.L. Benza, H.E. Grenett and F.M. Booyse, 2000. Activator promoter in cultured human endothelial cells transcription through cis- repressive region(s) in the tissue plasminogen hypertriglyceridemic VLDL downregulates tissue plasminogen activator gene. Arterioscler. Thromb. Vasc. Biol., 20: 1675-1681. PMID: 10845888
41. Tripathy, D., P. Mohanty, S. Dhindsa, T. Syed and H. Ghanim et al., 2003. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes, 52: 2882-2887. PMID: 14633847
42. Turner, R.C., J.C. Levy, A.S. Rudesnki, M. Hammersley and R. Page, 1993. Measurement of Insulin Resistance and β-Cell Function: The HOMA and CIGMA Approach. In: Current Topics in Diabetes Research, Belfiore, F., R. Bergman and G. Molinatti (Eds.). Basel, Karger, 12: 66-75.
43. Verma, S. and T.J. Anderson, 2002. Fundamentals of endothelial function for the clinical cardiologist. Circulation, 105: 546-549. PMID: 11827916
44. Vogel, R.A., M.C. Corretti and G.D. Plotnick, 1997. Effect of a single high-fat meal on endothelial function in healthy subjects. Am. J. Cardiol., 79: 350-354. PMID: 9036757
45. Williams, S.B., A.B. Goldfine, F.K. Timimi, H.H. Ting and M.A. Roddy et al., 1998. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation, 97: 1695-1701. PMID: 9591763
46. Woods, M., J.A. Mitchell, E.G. Wood, S. Barker and N.R. Walcot et al., 1999. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Mol. Pharmacol., 55: 902-909. PMID: 10220569
47. Zavaroni, I., E. Dall'Aglio and O. Alpi, F. Bruschi and E. Bonora et al., 1985. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis, 55: 259-266. PMID: 3893447
48. Zhang, L., A. Zalewski, Y. Liu, T. Mazurek and S. Cowan et al., 2003. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation, 108: 472-478. PMID: 12860917